(OMED) - Earnings & Price History

OMED: - 4.15, $154.28M, 0.12 (2.98%)

Sector: Healthcare - Industry: Biotechnology

OncoMed Pharmaceuticals, Inc., a clinical development-stage biopharmaceutical company, discovers and develops novel anti-cancer stem cell (CSC) and immuno-oncology therapeutics. The companys product candidates and preclinical programs include demcizumab (anti-DLL4, OMP-21M18), a humanized monoclonal antibody, which is in two Phase II clinical trials for non-small cell lung cancer and pancreatic cancer patients; tarextumab (anti-Notch2/3, OMP-59R5) that targets the Notch2 and Notch3 receptors, which is in Phase II clinical trial for small cell lung cancer patients; vantictumab (anti-Fzd7, OMP-18R5) that is in two Phase Ib clinical trials for breast cancer and pancreatic cancer patients; ipafricept (Fzd8-Fc, OMP-54F28), a fusion protein based Frizzled8 receptor or Fzd8, which is in two Phase Ib clinical trials for pancreatic and ovarian cancer patients; and brontictuzumab (anti-Notch1, OMP

Past OMED reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-08AMC-0.689.249.149.29.210.190.66%0.43%1.09%402.41K
2016-11-01AMC-0.778.718.979.498.079.495.80%▲-8.22%-2.90%232.25K
2016-08-09-0.8111.551212.1511.4812.21.25%-4.94%-3.75%91.44K
2016-05-05-0.7310.2410.9910.59.5210.63-4.46%-2.48%-6.82%270.28K
2016-03-10AMC0.4110.8110.7710.39.7310.98-4.36%4.95%0.37%404.21K
2015-11-05BMO-0.7721.7321.372120.8322-1.73%▲3.48%1.68%88.99K
2015-08-10AMC-0.4920.7622.4720.8319.4921.19-7.30%-0.34%-7.61%216.77K
2015-08-05AMC-0.4322.9822.922.922.5623.210.35%0.35%10.55K
2015-05-07AMC-0.3523.7723.1723.422.724.180.99%1.58%2.59%143.37K
2015-03-12AMC-0.2727.1928.172826.1828.08-0.60%-2.89%-3.48%182.41K
2014-11-04AMCOncomed Pharma-0.21-0.1819.6919.942019.0720.130.30%▲-1.55%-1.25%125.40K
2014-09-02Oncomed Pharma-0.03-0.5318.7219.4519.4918.119.90.21%-3.95%-3.75%309.40K
2014-06-17Oncomed Pharma-0.16-0.4725.9525.0825.0124.7425.98-0.28%3.76%3.47%226.40K
2014-03-18Oncomed Pharma0.05-0.1536.0234.9233.2233.2236.96-4.87%8.43%3.15%269.90K
2013-12-03Oncomed Pharma0.12-0.1529.6527.730.1527.732.398.84%▲-1.66%7.04%2.86M

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades